What is Arzerra used for?
Arzerra is a brand-name prescription drug that’s FDA-approved to treat chronic lymphocytic leukemia (CLL). CLL is a type of cancer that affects your white blood cells. Arzerra is approved for use in adults with: CLL that has never been treated, and fludarabine-based treatment can’t be used.
What type of medication is Arzerra?
Arzerra (ofatumumab) is a monoclonal antibody that affects the actions of the body’s immune system. Monoclonal antibodies are made to target and destroy only certain cells in the body. This may help to protect healthy cells from damage. Arzerra is used to treat chronic lymphocytic leukemia (CLL).
Is ofatumumab a chemotherapy?
Ofatumumab is the generic name for the trade chemotherapy drug Arzerra. In some cases, health care professionals may use the trade name Arzerra when referring to the generic drug name Ofatumumab. Drug Type: Ofatumumab is an anti-cancer (“antineoplastic” or “cytotoxic”) chemotherapy drug.
What are the side effects of Kesimpta?
Side effects of Kesimpta include:
- upper respiratory tract infection,
- headache,
- injection-related reactions (fever, headache, muscle pain, chills, and fatigue), and.
- local injection site reactions (redness, pain, itching, and swelling)
Is chlorambucil a chemotherapy?
Chlorambucil is a chemotherapy drug and is also known by its brand name Leukeran. It is used mainly to treat: chronic lymphocytic leukaemia (CLL) Non-Hodgkin lymphoma.
Who makes Ibrutinib?
IMBRUVICA® is a once-daily, first-in-class Bruton’s tyrosine kinase (BTK) inhibitor that is administered orally, and is jointly developed and commercialized by Janssen Biotech, Inc. and Pharmacyclics LLC, an AbbVie company.
How long do you take Kesimpta?
KESIMPTA is a flexible, once-monthly treatment that you can take from the comfort of home. You’ll give yourself 1 dose per week for the first 3 weeks, and then you’ll skip a week. After that, you can move on to 1 dose per month. You’ll give yourself 1 dose per week for the first 3 weeks, and then you’ll skip a week.
What is ofatumumab used for?
Ofatumumab injection is used in combination with chlorambucil to treat a type of cancer of the white blood cells called chronic lymphocytic leukemia (CLL) in patients who have not received any treatments in the past.
Is Kesimpta better than Ocrevus?
The safety and efficacy data of Ocrevus is, overall, comparable with that of Kesimpta. The main differentiation between the two drugs is the delivery system and the annual cost of therapy, which is $65,000 for Ocrevus compared to $83,000 for Kesimpta in the US.
Can Kesimpta cause hair loss?
Does Kesimpta cause hair loss or weight gain? No, these weren’t reported as side effects in clinical trials of the drug. Symptoms of multiple sclerosis (MS), the condition that Kesimpta is used to treat, may lead to weight changes.
What does chlorambucil do?
Chlorambucil is used treat a certain type of chronic lymphocytic leukemia (CLL; a type of cancer of the white blood cells). Chlorambucil is also used to treat non-Hodgkin’s lymphoma (NHL) and Hodgkin’s disease (types of cancer that begin in certain white blood cells that normally fight infection).
What happens if you touch chlorambucil?
Severe skin reactions warning: This drug can cause severe skin reactions. These can be fatal (cause death). Let your doctor know if you have any signs of a skin reaction. Symptoms include a severe rash, painful sores, blistering skin, or peeling skin.
What are the risks of Arzerra?
Arzerra increases the risk of a serious viral infection of the brain that can lead to disability or death. This risk is higher if you have a weak immune system or are receiving certain medicines. To make sure Arzerra is safe for you, tell your doctor if you have: an active infection; hepatitis; or.
What happens if Arzerra is discontinued?
If an anaphylactic reaction occurs, immediately and permanently discontinue Arzerra and initiate appropriate medical treatment. Hepatitis B virus (HBV) reactivation, in some cases resulting in fulminant hepatitis, hepatic failure, and death, has occurred in patients treated with Arzerra.
How is Arzerra given?
Arzerra is given as an infusion into a vein. A healthcare provider will give you this injection. You may be given other medications to help prevent a reaction to the infusion.
What happens if you get PML while taking Arzerra?
PML is a rare but serious infection that affects your brain. It has occurred in people taking Arzerra, and it’s even caused death. Symptoms of PML include weakness, vision problems, changes in personality, or trouble speaking. Your doctor will monitor you for signs of PML while you’re taking Arzerra.